UBS AM’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-85,566
| Closed | -$465K | – | 2692 |
|
|
2024
Q4 | $465K | Buy |
85,566
+13,417
| +19% | +$72.9K | ﹤0.01% | 2563 |
|
|
2024
Q3 | $521K | Sell |
72,149
-10,027
| -12% | -$72.4K | ﹤0.01% | 2634 |
|
|
2024
Q2 | $892K | Buy |
82,176
+21,611
| +36% | +$235K | ﹤0.01% | 2434 |
|
|
2024
Q1 | $1.13M | Buy |
60,565
+5,305
| +10% | +$99.4K | ﹤0.01% | 1945 |
|
|
2023
Q4 | $1.2M | Buy |
55,260
+11,183
| +25% | +$242K | ﹤0.01% | 1929 |
|
|
2023
Q3 | $907K | Hold |
44,077
| – | – | ﹤0.01% | 2003 |
|
|
2023
Q2 | $1.85M | Hold |
44,077
| – | – | ﹤0.01% | 1695 |
|
|
2023
Q1 | $1.85M | Buy |
44,077
+1,985
| +5% | +$83.3K | ﹤0.01% | 1695 |
|
|
2022
Q4 | $1.61M | Buy |
42,092
+2,288
| +6% | +$87.3K | ﹤0.01% | 1636 |
|
|
2022
Q3 | $1.56M | Sell |
39,804
-12,263
| -24% | -$480K | ﹤0.01% | 1725 |
|
|
2022
Q2 | $1.68M | Sell |
52,067
-22,054
| -30% | -$712K | ﹤0.01% | 1695 |
|
|
2022
Q1 | $2.45M | Sell |
74,121
-83,316
| -53% | -$2.76M | ﹤0.01% | 1695 |
|
|
2021
Q4 | $6.7M | Sell |
157,437
-695
| -0.4% | -$29.6K | ﹤0.01% | 1279 |
|
|
2021
Q3 | $7.01M | Buy |
158,132
+394
| +0.2% | +$17.5K | ﹤0.01% | 1225 |
|
|
2021
Q2 | $8.96M | Sell |
157,738
-39,896
| -20% | -$2.27M | ﹤0.01% | 1162 |
|
|
2021
Q1 | $14.8M | Sell |
197,634
-211,166
| -52% | -$15.8M | 0.01% | 955 |
|
|
2020
Q4 | $35.4M | Sell |
408,800
-36,575
| -8% | -$3.16M | 0.02% | 699 |
|
|
2020
Q3 | $27.2M | Buy |
445,375
+4,529
| +1% | +$277K | 0.01% | 684 |
|
|
2020
Q2 | $18.3M | Buy |
440,846
+182,906
| +71% | +$7.61M | 0.01% | 761 |
|
|
2020
Q1 | $7.41M | Sell |
257,940
-22,119
| -8% | -$635K | 0.01% | 943 |
|
|
2019
Q4 | $20.2M | Buy |
280,059
+96,854
| +53% | +$6.99M | 0.01% | 773 |
|
|
2019
Q3 | $25.7M | Sell |
183,205
-39,050
| -18% | -$5.48M | 0.02% | 698 |
|
|
2019
Q2 | $40.7M | Buy |
222,255
+20,597
| +10% | +$3.77M | 0.03% | 584 |
|
|
2019
Q1 | $32.1M | Buy |
201,658
+14,300
| +8% | +$2.27M | 0.02% | 623 |
|
|
2018
Q4 | $17.9M | Buy |
187,358
+6,232
| +3% | +$597K | 0.02% | 727 |
|
|
2018
Q3 | $25.6M | Buy |
181,126
+4,225
| +2% | +$597K | 0.02% | 688 |
|
|
2018
Q2 | $27.7M | Buy |
176,901
+2,484
| +1% | +$389K | 0.02% | 686 |
|
|
2018
Q1 | $28.1M | Sell |
174,417
-1,213
| -0.7% | -$195K | 0.02% | 686 |
|
|
2017
Q4 | $28.9M | Sell |
175,630
-58,396
| -25% | -$9.62M | 0.02% | 639 |
|
|
2017
Q3 | $14.6M | Buy |
234,026
+10,283
| +5% | +$641K | 0.01% | 817 |
|
|
2017
Q2 | $17.8M | Sell |
223,743
-9,339
| -4% | -$744K | 0.02% | 769 |
|
|
2017
Q1 | $16.6M | Sell |
233,082
-149,167
| -39% | -$10.6M | 0.02% | 770 |
|
|
2016
Q4 | $19.5M | Sell |
382,249
-8,157
| -2% | -$417K | 0.02% | 691 |
|
|
2016
Q3 | $18M | Buy |
390,406
+59,350
| +18% | +$2.73M | 0.02% | 715 |
|
|
2016
Q2 | $9.97M | Buy |
331,056
+242,064
| +272% | +$7.29M | 0.01% | 882 |
|
|
2016
Q1 | $2.85M | Sell |
88,992
-3,999
| -4% | -$128K | ﹤0.01% | 1221 |
|
|
2015
Q4 | $5.42M | Buy |
92,991
+40,904
| +79% | +$2.38M | 0.01% | 1043 |
|
|
2015
Q3 | $2.2M | Buy |
52,087
+916
| +2% | +$38.8K | ﹤0.01% | 1381 |
|
|
2015
Q2 | $3.74M | Buy |
51,171
+3,071
| +6% | +$224K | ﹤0.01% | 1142 |
|
|
2015
Q1 | $2.42M | Sell |
48,100
-1,200
| -2% | -$60.3K | ﹤0.01% | 1285 |
|
|
2014
Q4 | $1.8M | Buy |
49,300
+11,700
| +31% | +$428K | ﹤0.01% | 1365 |
|
|
2014
Q3 | $1.18M | Buy |
+37,600
| New | +$1.18M | ﹤0.01% | 1503 |
|